pipette
ESEspañol

Spatial context of cellular heterogeneity in triple-negative breast cancer reveals actionable subtypes

Z. Mesrizadeh, K. Mukund, L. Yang, R. K. Pillai, D. E. Frankhouser, D. Schmolze, S. L. Neuhausen, J. Zabaleta, L. D. Valle, J. Tomsic, Y. C. Ding, A. Ochoa, L. Miele, V. Seewaldt, S. Subramaniam

PreprintReal-world use

In the authors' words

Triple-negative breast cancer (TNBC) is an aggressive, heterogeneous disease with limited targeted treatment options. Leveraging bulk and spatial transcriptomics and cellular mapping of breast tissue from a large patient cohort, we identified three reproducible TNBC ecosystem subtypes that encode distinct spatial tumor-microenvironment architectures and clinically relevant treatment-response phenotype. Our analyses define: (1) an immune-exhausted subtype associated with immune checkpoint therapy (ICT); (2) a highly fibrotic/hypoxic subtype; and (3) a metabolically reprogrammed subtype characterized by nuclear-receptor and fatty-acid signaling. Spatial profiling further revealed subtype-specific organization of epithelial, immune, and stromal programs across tumor centers and invasive edges. Multiplexed imaging independently supported the contrasting immune-infiltrated and stromal-excluded architectures of the immune-engaged and fibrotic subtypes. The unique markers associated with the subtypes also provide the basis for subtyping and candidate therapeutic vulnerabilities. Our study provides a robust framework for personalized medicine, highlighting that targeting specific spatio-cellular architectures is critical to improving clinical outcomes.

Main resultThe abstract does not state a limitation.

Appeared: Wednesday, October 14. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.10.758236